方盛制药(603998.SH)发布前三季度业绩，归母净利润2.68亿元，同比增长17.6%

Core Insights - The company reported a revenue of 1.253 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 7.02% [1] - The net profit attributable to shareholders increased to 268 million yuan, showing a year-on-year growth of 17.6% [1] - The non-recurring net profit reached 213 million yuan, reflecting a year-on-year increase of 30.54% [1] - The basic earnings per share stood at 0.61 yuan [1]